Competition Government Pharmaceutical products 
pharmaphorum
JULY 27, 2022
Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”.
Contrarian Sales Techniques
DECEMBER 9, 2024
When people think of medical sales, they often picture a rep armed with clinical data and technical knowledge, pitching the latest pharmaceutical product or medical device. But what truly sets successful reps apartespecially in multinational pharmaceutical companies (MNCs) is not just what they know, but how they connect.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medico Reach
DECEMBER 2, 2022
Pharmaceutical Product Development (PPD). PPD, also known as Pharmaceutical Product Development, is an extensive research organization headquartered in the United States but has a widespread global presence. Founded: 1985 Headquarters: Wilmington, North Carolina Annual Revenue: $65.0M Employee Size: 24,000.
Pharmaceutical Representative Training
MARCH 17, 2025
One of the most difficult parts of introducing a pharmaceutical product is the regulatory environment. Pricing based on value is becoming more and more important to governments and private payers, therefore pharmaceutical companies need to make it obvious that their products have both therapeutic and financial benefits.
European Pharmaceutical Review
JUNE 24, 2022
If we concentrate on cost, EU governments like to focus on out-of-pocket expenses for costing R&D, for example, the amount of money you pay a contract research organisation to conduct a clinical trial for your product. Maarten has significant competition law experience in a variety of sectors. About the author. References.
European Pharmaceutical Review
SEPTEMBER 29, 2022
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme. About the auth or.
Pharma Marketing Network
OCTOBER 3, 2024
In the competitive landscape of the pharmaceutical industry, effective marketing strategies are crucial for brand success. Pharmaceutical marketing is not just about reaching healthcare professionals and patients; it involves a complex interplay of understanding market dynamics, regulatory compliance, and leveraging digital platforms.
Expert insights. Personalized for you.
98 
Let's personalize your content